Reno, NV USA aggregates that exploit the efficient selftemplating capacity of amyloid. The de novo appearance of these prions starts from the formation of small seeds, composed of molecules of the same protein that undergo conformational conversion into amyloid. Prion propagation proceeds by the addition of more molecules of the same protein to the infectious ends of the amyloid seeds leading to aggregate growth. This is followed by fragmentation of the aggregate, which creates new seeds with infectious ends.
aggregates that exploit the efficient selftemplating capacity of amyloid. The de novo appearance of these prions starts from the formation of small seeds, composed of molecules of the same protein that undergo conformational conversion into amyloid. Prion propagation proceeds by the addition of more molecules of the same protein to the infectious ends of the amyloid seeds leading to aggregate growth. This is followed by fragmentation of the aggregate, which creates new seeds with infectious ends. 1 Amyloid-based prions were first discovered as infectious proteins associated with neurodegenerative diseases. Their appearance was attributed to sporadic or mutation-driven misfolding of the PrP protein. 2 It now appears that multiple proteins in various organisms maintain the ability to fold in prion or prion-like states, and that some of these prions can be beneficial. 1, 3 Most known prion-forming proteins contain conserved functional domain(s) responsible for the protein's cellular activity, and a much less conserved prion domain that is responsible for aggregation and maintenance of the prion state. Several distinct structures have been described for prion domains of amyloid-based prions. All of them contain an ordered and extensive network of intermolecular bonds. Curiously there are many different selfseeding amyloid forms possible for most prion proteins. These different forms are called prion variants and often result in distinct phenotypic and biochemical properties. 1, 4 The most common type of prion domain is characterized by a very high ExtrA ViEw ExtrA ViEw tips of the preexisting prion could result in "capping" of these growing tips, leading to a negative prion-prion interaction (Fig. 1B) . Also, lateral association of heterologous prion aggregates could enlarge prion particles and interfere with their transmission to daughter cells (Fig. 1C) .
The second mechanism explains both positive and negative prion-prion interactions by a shift in the availability of factors, e.g., chaperones, involved in prion appearance or propagation ( Fig. 1D-F ). Titration models (Fig. 1D) propose that prions can bind such factors pulling them away from the cytoplasm. This could lead to a positive or negative prion-prion interaction depending on [21] [22] [23] [24] Two principally different mechanisms were proposed for interactions between heterologous prion proteins. 12, 14, 16, 18, 19, [23] [24] [25] The first postulates direct interaction of heterologous prion domains (Fig. 1A-C) . If the pre-existing prion were used as a nidus for initial aggregation of the newly forming prion, this would lead to a positive prion-prion interaction, a phenomenon known as seeding or cross-seeding (Fig. 1A) . However, a similar direct interaction between the overexpressed heterologous protein and the growing proportion of polar uncharged glutamine and asparagine (Q/N) residues. Low complexity of primary structure and, especially, a low content of structurepromoting hydrophobic and charged amino acids, keeps these domains unstructured in the monomeric state, thus simplifying conformational switching. In the prion state, the Q and N residues engage in intermolecular interactions leading to the formation of monotonous β-rich aggregates. 5, 6 Genes encoding potentially prionogenic Q/N-rich domains constitute up to 5% of eukaryotic genomes, 7 and, strikingly, most of these Q/N-rich sequences are indeed prone to drive the formation of prion-like aggregates in vivo and in vitro. [8] [9] [10] in cells overexpressing Pin4C, we used a strain, in which the chromosomal SUP35 ORF was replaced by a fully functional SUP35-GFP fusion. 30 This strain can stably maintain strong [PSI + ] variants that are visualized as tiny fluorescent foci. PIN4C was introduced on a multicopy plasmid under the control of a tightly regulated GAL promoter. Overnight overexpression of Pin4C caused the Sup35-GFP aggregates to become brighter and bigger in 80% of cells (Fig. 2C) . As yeast prion aggregates have been shown to be composed of SDS-resistant oligomers, 31 we also analyzed the size of [PSI + ] oligomers resistant to 2% SDS at room temperature in Pin4C overexpressing cells. Indeed, the enlargement of visible Sup35-GFP aggregates caused by overexpression of Pin4C, coincided with an increase of the size of SDS-resistant Sup35-GFP oligomers (Fig. 2C) In our recently published study, 27 we explore negative prion-prion interactions. We find that negative interactions leading to destabilization of pre-existing prions upon overexpression of proteins with Q/N-rich prion domains are widespread. We also provide evidence supporting both chaperone titration and chaperone induction mechanisms for these interactions.
Negative Prion-Prion Interactions are Widespread but are Prion-Specific and Prion Variant-Specific
Our study 27 Pin4C-dsRED foci and the enlargement of Sup35-GFP foci, underscoring the link between these events. (Fig. 1F) . The overexpressed Hsp104 appears to outcompete Hsp70/Hsp40 for binding to [PSI + ] and is then unable to fragment it. 37, 38 On the contrary, Ure2, like most other prion-forming proteins, does not bind Hsp104 in the absence of Ssa1, and is thus not cured by Hsp104 overexpression, 33, 39 so overexpression of Cyc8C is not expected to cure [URE3]. Thus we conclude that the curing specificity of Cyc8C is consistent with the induction model.
Curing of [PSI
The key consequence, however, is not the unfolding of the threaded molecule, but the breaking of the prion aggregate at the site, where the molecule was removed. The Ssa Hsp70s recognize the prion aggregate, and attract Sis1 Hsp40, which facilitates the binding of Hsp104 to the prion, while Sse1 and Fes1 act as nucleotide exchange factors for the Ssa's. 32 Thus, depletion of Hsp104, Sis1, or Hsp70 is expected to lead to the enlargement of prion oligomers, their poor transmission to daughter cells and, as a result, prion loss. 33 Western analyses showed that Pin4C overexpression did not significantly change the levels of these chaperones. There was a slight reduction in Hsp104 (to 83% of the normal level). However, this reduction was not sufficient to destabilize [PSI + ], since [PSI + ] remains stable even in strains expressing only 50% of the normal Hsp104. 34 However, fluorescence microscopy of cells expressing the endogenously-encoded Hsp104-GFP and overexpressing Pin4-dsRED revealed that, upon the formation of large Pin4C foci, most cellular Hsp104 shifted to these foci, leaving only ~33% of the normal Hsp104 level in the cytoplasm (Fig.  2D) , and association of Hsp104 with Pin4C was also confirmed by co-immunoprecipitation with anti-RFP antibody. This drop in available Hsp104 could be sufficient to promote destabilization of the prion. T160M was cooverexpressed with Pin4C, even though Pin4C continued to aggregate (Fig. 2E) .
Pin4C overexpression and aggregation also lead to dramatic changes in the cellular distribution of Sis1. While normally concentrated in the nucleus, in cells with Pin4C aggregates, Sis1 shifted from the nucleus to Pin4C foci, suggesting that titration of this co-chaperone could also contribute to the [PSI + ]-curing effect of Pin4C. Indeed, Sis1 cooverexpression significantly reduced [PSI + ] loss in Pin4C overexpressing cells (Fig. 2E) . Furthermore, Sis1 overexpression prevented both the appearance of large the finding of enlarged Sup35-GFP aggregates is obviously inconsistent with the capping model, where [PSI + ] is proposed to be cured by the incorporation of Pin4C at the Sup35-GFP fiber ends, thereby preventing Sup35-GFP aggregate growth. Indeed, capping would lead to a diminution of Sup35-GFP foci, not their enlargement. A model that proposes the formation of mixed amyloid structures via lateral association of heterologous aggregates is consistent with the finding that Pin4C overexpression leads to the enlargement and reduced mobility of [PSI + ] aggregates However, this model predicts co-localization of Pin4C with Sup35-GFP aggregates, which was not found. When we expressed a PIN4C-dsRED fusion controlled by a GAL promoter in a [PSI + ] SUP35-GFP strain, we saw multiple bright cytoplasmic Pin4C-dsRED foci that became larger and less numerous in a few hours and by 24 h usually formed one large focus per cell. These large Pin4C-dsRED foci were accompanied by the appearance of enlarged Sup35-GFP foci, but co-localization of Pin4C-dsRED and Sup35-GFP foci was never observed (Fig. 2C) . Furthermore, prion aggregate enlargement due to increased lateral association of prion aggregates should occur in the absence of the continuous synthesis of the prionforming protein. However, we found that in the absence of newly synthesized Sup35-GFP, the foci remained small and dim. Thus we found no support for models implying direct interactions of prionforming proteins.
Curing of [PSI + ] in Pin4C-Overexpressing Cells is Caused by the Titration of the Hsp104 and Sis1 Chaperones by Pin4C Aggregates
We then asked if our results could be explained by shifts in the availability of chaperones involved in prion propagation, focusing on Hsp70/40 and Hsp104. Current models suggest that Hsp104 pulls out individual protein molecules from linear prion aggregates to thread these molecules through its central pore, just as it does while disassembling stressinduced amorphous protein aggregates. , there is a key argument in favor of the induction model: an 8-fold increase in the Hsp104 level was observed and this increase is sufficient for curing. Thus there is strong support for two modes of negative prion-prion interactions, neither of which is based on the direct interaction of prion-forming proteins. We expect that as more prion proteins are identified, additional examples of indirect and new examples of direct interactions will be uncovered.
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all the above negative interactions are associated with enlargement of aggregates proposed to result from inefficient fragmentation and poor transmission to daughter cells. 25, [42] [43] [44] [45] However, while this is consistent with Hsp104 deficiency, a model postulating aggregate enlargement by direct lateral association of heterologous aggregates was favored (Fig. 1C) . 43, 44 The key arguments that favor lateral association over titration in the studies from the Nakamura and Yoshida labs are: (1) co-localization of prion aggregates with the aggregates of the curing protein; (2) 27 In conclusion, the key arguments in our work favoring Hsp104 titration (Fig. 1D ) over lateral association (Fig. 1C Below we discuss which of the models best explains other negative prion interactions both uncovered in our study and described elsewhere.
Curing of [URE3] by Pin3 overexpression is another example of a negative prion interaction with distinct specificity, revealed in our study. 27 (Fig. 1D) .
Several negative prion interactions were recently reported by the Nakamura and Yoshida labs. 25 44, 45 Similar to our observations for Pin4C, 27 
